SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-20-005865
Filing Date
2020-06-22
Accepted
2020-06-22 16:18:47
Documents
4
Period of Report
2020-06-18
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT admp-8k_061820.htm 8-K 41772
2 BYLAWS OF THE COMPANY ex3-1.htm EX-3.1 135767
3 DESCRIPTION OF THE REGISTRANT'S COMMON STOCK ex4-6.htm EX-4.6 49168
4 ADAMIS PHARMACEUTICALS CORPORATION BONUS PLAN ex10-1.htm EX-10.1 46534
  Complete submission text file 0001387131-20-005865.txt   274785
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36242 | Film No.: 20979050
SIC: 2834 Pharmaceutical Preparations